Lorne Albrecht

650 total citations
16 papers, 161 citations indexed

About

Lorne Albrecht is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Lorne Albrecht has authored 16 papers receiving a total of 161 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Dermatology, 8 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Lorne Albrecht's work include Dermatology and Skin Diseases (11 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and Autoimmune Bullous Skin Diseases (5 papers). Lorne Albrecht is often cited by papers focused on Dermatology and Skin Diseases (11 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and Autoimmune Bullous Skin Diseases (5 papers). Lorne Albrecht collaborates with scholars based in Canada, United States and Belgium. Lorne Albrecht's co-authors include Melinda Gooderham, Charles Lynde, Kim Papp, Adrian R. Levy, David Gratton, Gurbir Dhadwal, Yves Poulin, Robert Gniadecki, Jensen Yeung and Lawrence Green and has published in prestigious journals such as Journal of the American Academy of Dermatology, Archives of Dermatological Research and International Journal of Dermatology.

In The Last Decade

Lorne Albrecht

14 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorne Albrecht Canada 7 102 94 36 34 27 16 161
Ali Al‐Janabi United Kingdom 10 126 1.2× 100 1.1× 33 0.9× 30 0.9× 11 0.4× 16 200
M. Viguier France 7 144 1.4× 185 2.0× 10 0.3× 25 0.7× 44 1.6× 12 247
Robert Higham United States 5 65 0.6× 65 0.7× 23 0.6× 19 0.6× 8 0.3× 31 114
Chih-ho Hong Canada 11 219 2.1× 86 0.9× 128 3.6× 85 2.5× 11 0.4× 27 298
Federico Pirrò Italy 8 114 1.1× 157 1.7× 6 0.2× 43 1.3× 11 0.4× 11 205
Joachim Koza Switzerland 4 59 0.6× 82 0.9× 6 0.2× 16 0.5× 10 0.4× 4 104
G. E. van der Kraaij Netherlands 6 62 0.6× 80 0.9× 8 0.2× 16 0.5× 8 0.3× 9 124
L. Renda United States 5 107 1.0× 181 1.9× 4 0.1× 22 0.6× 34 1.3× 9 203
Sonja Senner Germany 5 79 0.8× 27 0.3× 35 1.0× 19 0.6× 6 0.2× 6 118
A.C.M. Kunkeler Netherlands 6 182 1.8× 58 0.6× 105 2.9× 56 1.6× 4 0.1× 9 215

Countries citing papers authored by Lorne Albrecht

Since Specialization
Citations

This map shows the geographic impact of Lorne Albrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorne Albrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorne Albrecht more than expected).

Fields of papers citing papers by Lorne Albrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorne Albrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorne Albrecht. The network helps show where Lorne Albrecht may publish in the future.

Co-authorship network of co-authors of Lorne Albrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Lorne Albrecht. A scholar is included among the top collaborators of Lorne Albrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorne Albrecht. Lorne Albrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Turchin, Irina, Lorne Albrecht, Wei Jing Loo, et al.. (2025). Current Understanding of Seborrheic Dermatitis: Epidemiology, Burden of Disease, and Pathophysiology. Journal of Cutaneous Medicine and Surgery. 29(4_suppl). 5S–15S. 1 indexed citations
2.
Turchin, Irina, Lorne Albrecht, Charles Lynde, et al.. (2025). Current Understanding of Seborrheic Dermatitis: Treatment Options. Journal of Cutaneous Medicine and Surgery. 29(4_suppl). 24S–36S. 2 indexed citations
3.
Turchin, Irina, Lorne Albrecht, Wei Jing Loo, et al.. (2025). Current Understanding of Seborrheic Dermatitis: Presentation, Diagnosis, and Special Populations. Journal of Cutaneous Medicine and Surgery. 29(4_suppl). 16S–23S. 3 indexed citations
4.
Albrecht, Lorne, Jennifer Beecker, Isabelle Delorme, et al.. (2024). 53822 Longitudinal evaluation of the psoriasis epidemiology screening tool (PEST) in patients with moderate to severe psoriasis: Results from the PURE Registry. Journal of the American Academy of Dermatology. 91(3). AB250–AB250.
5.
Papp, Kim, Melinda Gooderham, Charles Lynde, et al.. (2024). Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry. Archives of Dermatological Research. 316(7). 362–362. 1 indexed citations
6.
Gooderham, Melinda, Kim Papp, Charles Lynde, et al.. (2022). Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry. Dermatology and Therapy. 13(2). 535–553. 1 indexed citations
7.
Gold, Linda Stein, Kim Papp, David M. Pariser, et al.. (2022). Efficacy and safety of apremilast in patients with mild-to-moderate psoriasis up to 32 weeks: Results from the extension phase of the randomized, phase 3 ADVANCE trial. Journal of the American Academy of Dermatology. 88(2). 430–433.
8.
Gold, Linda Stein, Kim Papp, David M. Pariser, et al.. (2021). Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 86(1). 77–85. 38 indexed citations
9.
Hanke, C. William, Lorne Albrecht, Torsten Skov, et al.. (2019). Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm2 on the chest: A phase 3 randomized controlled trial. Journal of the American Academy of Dermatology. 82(3). 642–650. 7 indexed citations
10.
Papp, Kim, Melinda Gooderham, Jennifer Beecker, et al.. (2019). Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America. BMC Dermatology. 19(1). 9–9. 7 indexed citations
11.
Dhadwal, Gurbir, Lorne Albrecht, Robert Gniadecki, et al.. (2018). Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 22(1_suppl). 21S–29S. 20 indexed citations
13.
Gooderham, Melinda, Chih-ho Hong, Lorne Albrecht, et al.. (2018). Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Journal of Cutaneous Medicine and Surgery. 22(1_suppl). 3S–5S. 20 indexed citations
14.
Hong, Chih-ho, Melinda Gooderham, Lorne Albrecht, et al.. (2018). Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 22(1_suppl). 30S–35S. 6 indexed citations
15.
Levy, Adrian R., et al.. (2012). Economic burden of moderate to severe plaque psoriasis in Canada. International Journal of Dermatology. 51(12). 1432–1440. 45 indexed citations
16.
Albrecht, Lorne, Marc Bourcier, John Ashkenas, & Kim Papp. (2011). Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations. Journal of Cutaneous Medicine and Surgery. 15(6). 309–321. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026